Systemic tumor targeting and killing by Sindbis viral vectors
10.1038/nbt917
Crossref journal-article
Springer Science and Business Media LLC
Nature Biotechnology (297)
Bibliography

Tseng, J.-C., Levin, B., Hurtado, A., Yee, H., de Castro, I. P., Jimenez, M., Shamamian, P., Jin, R., Novick, R. P., Pellicer, A., & Meruelo, D. (2003). Systemic tumor targeting and killing by Sindbis viral vectors. Nature Biotechnology, 22(1), 70–77.

Authors 11
  1. Jen-Chieh Tseng (first)
  2. Brandi Levin (additional)
  3. Alicia Hurtado (additional)
  4. Herman Yee (additional)
  5. Ignacio Perez de Castro (additional)
  6. Maria Jimenez (additional)
  7. Peter Shamamian (additional)
  8. Ruzhong Jin (additional)
  9. Richard P Novick (additional)
  10. Angel Pellicer (additional)
  11. Daniel Meruelo (additional)
References 42 Referenced 117
  1. Akporiaye, E.T. & Hersh, E. Clinical aspects of intratumoral gene therapy. Curr. Opin. Mol. Ther. 1, 443–453 (1999). / Curr. Opin. Mol. Ther. by ET Akporiaye (1999)
  2. Green, N.K. & Seymour, L.W. Adenoviral vectors: systemic delivery and tumor targeting. Cancer Gene Ther. 9, 1036–1042 (2002). (10.1038/sj.cgt.7700541) / Cancer Gene Ther. by NK Green (2002)
  3. Biederer, C., Ries, S., Brandts, C.H. & McCormick, F. Replication-selective viruses for cancer therapy. J. Mol. Med. 80, 163–175 (2002). (10.1007/s00109-001-0295-1) / J. Mol. Med. by C Biederer (2002)
  4. Bredenbeek, P.J., Frolov, I., Rice, C.M. & Schlesinger, S. Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J. Virol. 67, 6439–6446 (1993). (10.1128/JVI.67.11.6439-6446.1993) / J. Virol. by PJ Bredenbeek (1993)
  5. Strauss, J.H. & Strauss, E.G. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev. 58, 491–562 (1994). (10.1128/MMBR.58.3.491-562.1994) / Microbiol. Rev. by JH Strauss (1994)
  6. Ryman, K.D., Klimstra, W.B., Nguyen, K.B., Biron, C.A. & Johnston, R.E. α/β interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J. Virol. 74, 3366–3378 (2000). (10.1128/JVI.74.7.3366-3378.2000) / J. Virol. by KD Ryman (2000)
  7. Cook, S.H. & Griffin, D.E. Luciferase imaging of a neurotropic viral infection in intact animals. J. Virol. 77, 5333–5338 (2003). (10.1128/JVI.77.9.5333-5338.2003) / J. Virol. by SH Cook (2003)
  8. Tseng, J.C. et al. In vivo antitumor activity of Sindbis viral vectors. J. Natl. Cancer Inst. 94, 1790–1802 (2002). (10.1093/jnci/94.23.1790) / J. Natl. Cancer Inst. by JC Tseng (2002)
  9. Wang, K.S., Kuhn, R.J., Strauss, E.G., Ou, S. & Strauss, J.H. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J. Virol. 66, 4992–5001 (1992). (10.1128/JVI.66.8.4992-5001.1992) / J. Virol. by KS Wang (1992)
  10. Strauss, J.H., Wang, K.S., Schmaljohn, A.L., Kuhn, R.J. & Strauss, E.G. Host-cell receptors for Sindbis virus. Arch. Virol. Suppl. 9, 473–484 (1994). / Arch. Virol. Suppl. by JH Strauss (1994)
  11. Martignone, S. et al. Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. J. Natl. Cancer Inst. 85, 398–402 (1993). (10.1093/jnci/85.5.398) / J. Natl. Cancer Inst. by S Martignone (1993)
  12. Sanjuan, X. et al. Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma. J. Pathol. 179, 376–380 (1996). (10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V) / J. Pathol. by X Sanjuan (1996)
  13. de Manzoni, G. et al. Study on Ki-67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer. Jpn. J. Clin. Oncol. 28, 534–537 (1998). (10.1093/jjco/28.9.534) / Jpn. J. Clin. Oncol. by G de Manzoni (1998)
  14. Taraboletti, G., Belotti, D., Giavazzi, R., Sobel, M.E. & Castronovo, V. Enhancement of metastatic potential of murine and human melanoma cells by laminin receptor peptide G: attachment of cancer cells to subendothelial matrix as a pathway for hematogenous metastasis. J. Natl. Cancer Inst. 85, 235–240 (1993). (10.1093/jnci/85.3.235) / J. Natl. Cancer Inst. by G Taraboletti (1993)
  15. Ozaki, I. et al. Differential expression of laminin receptors in human hepatocellular carcinoma. Gut 43, 837–842 (1998). (10.1136/gut.43.6.837) / Gut by I Ozaki (1998)
  16. van den Brule, F.A. et al. Expression of the 67 kD laminin receptor in human ovarian carcinomas as defined by a monoclonal antibody, MLuC5. Eur. J. Cancer 32A, 1598–1602 (1996). (10.1016/0959-8049(96)00119-0) / Eur. J. Cancer by FA van den Brule (1996)
  17. van den Brule, F.A. et al. Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. Eur. J. Cancer 30A, 1096–1099 (1994). (10.1016/0959-8049(94)90464-2) / Eur. J. Cancer by FA van den Brule (1994)
  18. Liebman, J.M., Burbelo, P.D., Yamada, Y., Fridman, R. & Kleinman, H.K. Altered expression of basement-membrane components and collagenases in ascitic xenografts of OVCAR-3 ovarian cancer cells. Int. J. Cancer 55, 102–109 (1993). (10.1002/ijc.2910550119) / Int. J. Cancer by JM Liebman (1993)
  19. Cioce, V. et al. Increased expression of the laminin receptor in human colon cancer. J. Natl. Cancer Inst. 83, 29–36 (1991). (10.1093/jnci/83.1.29) / J. Natl. Cancer Inst. by V Cioce (1991)
  20. Menard, S., Tagliabue, E. & Colnaghi, M.I. The 67 kDa laminin receptor as a prognostic factor in human cancer. Breast. Cancer. Res. Treat. 52, 137–145 (1998). (10.1023/A:1006171403765) / Breast. Cancer. Res. Treat. by S Menard (1998)
  21. Viacava, P. et al. The spectrum of 67-kD laminin receptor expression in breast carcinoma progression. J. Pathol. 182, 36–44 (1997). (10.1002/(SICI)1096-9896(199705)182:1<36::AID-PATH802>3.0.CO;2-W) / J. Pathol. by P Viacava (1997)
  22. Liotta, L.A. Tumor invasion and metastases—role of the extracellular matrix: Rhoads Memorial Award lecture. Cancer Res. 46, 1–7 (1986). (10.1016/S0065-230X(08)60034-2) / Cancer Res. by LA Liotta (1986)
  23. Aznavoorian, S., Murphy, A.N., Stetler-Stevenson, W.G. & Liotta, L.A. Molecular aspects of tumor cell invasion and metastasis. Cancer 71, 1368–1383 (1993). (10.1002/1097-0142(19930215)71:4<1368::AID-CNCR2820710432>3.0.CO;2-L) / Cancer by S Aznavoorian (1993)
  24. Liotta, L.A., Rao, N.C., Barsky, S.H. & Bryant, G. The laminin receptor and basement membrane dissolution: role in tumour metastasis. Ciba Found. Symp. 108, 146–162 (1984). / Ciba Found. Symp. by LA Liotta (1984)
  25. Levine, B. et al. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361, 739–742 (1993). (10.1038/361739a0) / Nature by B Levine (1993)
  26. Jan, J.T., Chatterjee, S. & Griffin, D.E. Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J. Virol. 74, 6425–6432 (2000). (10.1128/JVI.74.14.6425-6432.2000) / J. Virol. by JT Jan (2000)
  27. Jan, J.T. & Griffin, D.E. Induction of apoptosis by Sindbis virus occurs at cell entry and does not require virus replication. J. Virol. 73, 10296–10302 (1999). (10.1128/JVI.73.12.10296-10302.1999) / J. Virol. by JT Jan (1999)
  28. Balachandran, S. et al. α/β interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J. Virol. 74, 1513–1523 (2000). (10.1128/JVI.74.3.1513-1523.2000) / J. Virol. by S Balachandran (2000)
  29. Frolov, I. & Schlesinger, S. Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells. J. Virol. 68, 1721–1727 (1994). (10.1128/JVI.68.3.1721-1727.1994) / J. Virol. by I Frolov (1994)
  30. Frolova, E.I. et al. Roles of nonstructural protein nsP2 and α/β interferons in determining the outcome of Sindbis virus infection. J. Virol. 76, 11254–11264 (2002). (10.1128/JVI.76.22.11254-11264.2002) / J. Virol. by EI Frolova (2002)
  31. Olivo, P.D., Frolov, I. & Schlesinger, S. A cell line that expresses a reporter gene in response to infection by Sindbis virus: a prototype for detection of positive strand RNA viruses. Virology 198, 381–384 (1994). (10.1006/viro.1994.1046) / Virology by PD Olivo (1994)
  32. Putzer, B.M., Rodicker, F., Hitt, M.M., Stiewe, T. & Esche, H. Improved treatment of pancreatic cancer by IL-12 and B7.1 costimulation: antitumor efficacy and immunoregulation in a nonimmunogenic tumor model. Mol. Ther. 5, 405–412 (2002). (10.1006/mthe.2002.0570) / Mol. Ther. by BM Putzer (2002)
  33. Liotta, L.A. et al. Monoclonal antibodies to the human laminin receptor recognize structurally distinct sites. Exp. Cell Res. 156, 117–126 (1985). (10.1016/0014-4827(85)90266-6) / Exp. Cell Res. by LA Liotta (1985)
  34. Barsky, S.H., Rao, C.N., Hyams, D. & Liotta, L.A. Characterization of a laminin receptor from human breast carcinoma tissue. Breast Cancer Res. Treat. 4, 181–188 (1984). (10.1007/BF01806483) / Breast Cancer Res. Treat. by SH Barsky (1984)
  35. Terranova, V.P., Rao, C.N., Kalebic, T., Margulies, I.M. & Liotta, L.A. Laminin receptor on human breast carcinoma cells. Proc. Natl. Acad. Sci. USA 80, 444–448 (1983). (10.1073/pnas.80.2.444) / Proc. Natl. Acad. Sci. USA by VP Terranova (1983)
  36. Byrnes, A.P. & Griffin, D.E. Binding of Sindbis virus to cell surface heparan sulfate. J. Virol. 72, 7349–7356 (1998). (10.1128/JVI.72.9.7349-7356.1998) / J. Virol. by AP Byrnes (1998)
  37. Leucht, C. et al. The 37 kDa/67 kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep. 4, 290–295 (2003). (10.1038/sj.embor.embor768) / EMBO Rep. by C Leucht (2003)
  38. Gauczynski, S. et al. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 20, 5863–5875 (2001). (10.1093/emboj/20.21.5863) / EMBO J. by S Gauczynski (2001)
  39. Yaghoubi, S.S. et al. Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors. Gene Ther. 8, 1072–1080 (2001). (10.1038/sj.gt.3301490) / Gene Ther. by SS Yaghoubi (2001)
  40. Adams, J.Y. et al. Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat. Med. 8, 891–897 (2002). (10.1038/nm743) / Nat. Med. by JY Adams (2002)
  41. Polo, J.M. et al. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. Proc. Natl. Acad. Sci. USA 96, 4598–4603 (1999). (10.1073/pnas.96.8.4598) / Proc. Natl. Acad. Sci. USA by JM Polo (1999)
  42. Antonio Chiocca, E. Oncolytic viruses. Nat. Rev. Cancer 2, 938–950 (2002). (10.1038/nrc948) / Nat. Rev. Cancer by E Antonio Chiocca (2002)
Dates
Type When
Created 21 years, 9 months ago (Nov. 30, 2003, 1:05 p.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 3:57 p.m.)
Indexed 3 months, 2 weeks ago (May 15, 2025, 6:27 a.m.)
Issued 21 years, 9 months ago (Nov. 30, 2003)
Published 21 years, 9 months ago (Nov. 30, 2003)
Published Online 21 years, 9 months ago (Nov. 30, 2003)
Published Print 21 years, 8 months ago (Jan. 1, 2004)
Funders 0

None

@article{Tseng_2003, title={Systemic tumor targeting and killing by Sindbis viral vectors}, volume={22}, ISSN={1546-1696}, url={http://dx.doi.org/10.1038/nbt917}, DOI={10.1038/nbt917}, number={1}, journal={Nature Biotechnology}, publisher={Springer Science and Business Media LLC}, author={Tseng, Jen-Chieh and Levin, Brandi and Hurtado, Alicia and Yee, Herman and de Castro, Ignacio Perez and Jimenez, Maria and Shamamian, Peter and Jin, Ruzhong and Novick, Richard P and Pellicer, Angel and Meruelo, Daniel}, year={2003}, month=nov, pages={70–77} }